Fulton Bank’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,895
| Closed | -$84.1K | – | 681 |
|
|
2025
Q3 | $84.1K | Sell |
10,895
-29
| -0.3% | -$203 | ﹤0.01% | 665 |
|
|
2025
Q2 | $79.9K | Buy |
10,924
+23
| +0.2% | +$186 | ﹤0.01% | 662 |
|
|
2025
Q1 | $103K | Sell |
10,901
-89
| -0.8% | -$1.11K | ﹤0.01% | 631 |
|
|
2024
Q4 | $181K | Hold |
10,990
| – | – | 0.01% | 648 |
|
|
2024
Q3 | $162K | Buy |
10,990
+38
| +0.3% | +$595 | 0.01% | 649 |
|
|
2024
Q2 | $152K | Hold |
10,952
| – | – | 0.01% | 612 |
|
|
2024
Q1 | $172K | Hold |
10,952
| – | – | 0.01% | 594 |
|
|
2023
Q4 | $177K | Hold |
10,952
| – | – | 0.01% | 577 |
|
|
2023
Q3 | $135K | Hold |
10,952
| – | – | 0.01% | 556 |
|
|
2023
Q2 | $176K | Hold |
10,952
| – | – | 0.01% | 543 |
|
|
2023
Q1 | $191K | Buy |
10,952
+173
| +2% | +$2.46K | 0.01% | 538 |
|
|
2022
Q4 | $100K | Sell |
10,779
-154
| -1% | -$1.44K | 0.01% | 519 |
|
|
2022
Q3 | $94K | Buy |
10,933
+154
| +1% | +$1.53K | 0.01% | 471 |
|
|
2022
Q2 | $88K | Hold |
10,779
| – | – | ﹤0.01% | 479 |
|
|
2022
Q1 | $131K | Hold |
10,779
| – | – | 0.01% | 501 |
|
|
2021
Q4 | $368K | Hold |
10,779
| – | – | 0.02% | 398 |
|
|
2021
Q3 | $520K | Hold |
10,779
| – | – | 0.02% | 318 |
|
|
2021
Q2 | $487K | Hold |
10,779
| – | – | 0.02% | 312 |
|
|
2021
Q1 | $520K | Hold |
10,779
| – | – | 0.03% | 290 |
|
|
2020
Q4 | $580K | Hold |
10,779
| – | – | 0.03% | 270 |
|
|
2020
Q3 | $398K | Hold |
10,779
| – | – | 0.02% | 295 |
|
|
2020
Q2 | $334K | Hold |
10,779
| – | – | 0.02% | 298 |
|
|
2020
Q1 | $298K | Sell |
10,779
-9,168
| -46% | -$275K | 0.02% | 294 |
|
|
2019
Q4 | $583K | Hold |
19,947
| – | – | 0.04% | 249 |
|
|
2019
Q3 | $381K | Hold |
19,947
| – | – | 0.03% | 281 |
|
|
2019
Q2 | $438K | Hold |
19,947
| – | – | 0.03% | 271 |
|
|
2019
Q1 | $408K | Sell |
19,947
-25,525
| -56% | -$444K | 0.03% | 277 |
|
|
2018
Q4 | $573K | Sell |
45,472
-24,570
| -35% | -$366K | 0.05% | 235 |
|
|
2018
Q3 | $1.07M | Hold |
70,042
| – | – | 0.07% | 193 |
|
|
2018
Q2 | $918K | Hold |
70,042
| – | – | 0.06% | 201 |
|
|
2018
Q1 | $572K | Hold |
70,042
| – | – | 0.04% | 249 |
|
|
2017
Q4 | $621K | Hold |
70,042
| – | – | 0.04% | 232 |
|
|
2017
Q3 | $780K | Hold |
70,042
| – | – | 0.06% | 192 |
|
|
2017
Q2 | $628K | Hold |
70,042
| – | – | 0.05% | 204 |
|
|
2017
Q1 | $553K | Hold |
70,042
| – | – | 0.05% | 211 |
|
|
2016
Q4 | $600K | Buy |
+70,042
| New | +$600K | 0.05% | 201 |
|
Other funds holding NEO
FLAM
GF
B
NAMI
Fulton Bank's NEO Position: Q4 2025 in Review
Fulton Bank sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 10,895 shares — an estimated $84.1K sold.
Fulton Bank first reported a position in NEO in Q4 2016 and held it in 36 quarters. The position peaked at $1.07M in Q3 2018. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.
- Fulton Bank reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
- Fulton Bank sold 10,895 NeoGenomics shares in Q4 2025, an estimated $84.1K.
- Fulton Bank first reported a position in NeoGenomics in Q4 2016 and held it in 36 quarters.
- Fulton Bank's NeoGenomics position peaked at $1.07M in Q3 2018.
- 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.
Based on Fulton Bank's 13F filing for Q4 2025, filed 8 Jan 2026.